This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 Low Price-to-Sales Stocks to Get the Best of the Market
by Rajani Lohia
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like KBH, MFIN, PLUS, CRAI and PAGS hold promise.
What Makes ePlus (PLUS) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does ePlus (PLUS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Industry Outlook Highlights MSCI, Tyler Technologies, Guidewire Software and ePlus
by Zacks Equity Research
MSCI, Tyler Technologies, Guidewire Software and ePlus are part of the Zacks Industry Outlook article.
4 Business-Software Services Stocks to Watch in a Prospering Industry
by Anirudha Bhagat
The Zacks Business-Software Services industry players like MSCI, TYL, GWRE and PLUS are poised to benefit from the robust demand trend for multi-cloud-enabled software solutions.
Fight August Volatility With 'Strong Buy' Stocks Trading Near Highs
by Benjamin Rains
Investors likely want to search for stocks that have boosted their earnings outlooks recently and are still trading near their highs through the somewhat rocky start to August...
Best Momentum Stocks to Buy for August 14th
by Zacks Equity Research
PLUS, KRT and FDUS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 14, 2023.
EPlus (PLUS) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
ePlus (PLUS) delivered earnings and revenue surprises of 42.42% and 17.77%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Cognizant (CTSH) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cognizant (CTSH) delivered earnings and revenue surprises of 13.40% and 1.50%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
5 Low Price-to-Sales Stocks That Promise Lucrative Returns
by Rajani Lohia
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like CRUS, PLUS, GIII, JAKK and UFPI hold promise.
5 Low Price-to-Sales Stocks to Keep Your Investments Safe
by Rajani Lohia
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like B, PLUS, GIII, PAM and UFPI hold promise.
Fast-paced Momentum Stock ePlus (PLUS) Is Still Trading at a Bargain
by Zacks Equity Research
ePlus (PLUS) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Cognizant (CTSH) Partners With Accuray to Improve Healthcare
by Zacks Equity Research
Cognizant's (CTSH) partnership agreement will enable Accuray to streamline and drive operational changes to improve patient care.
Zacks Investment Ideas feature highlights: ePlus, Rush Enterprises and Sterling Infrastructure
by Zacks Equity Research
ePlus, Rush Enterprises and Sterling Infrastructure have been highlighted in this Investment Ideas article.
3 Intriguing Stocks to Buy for Value and Growth Potential
by Shaun Pruitt
These companies are attractively placed in their industries as leaders that can benefit from economic expansion.
5 Low Price-to-Sales Stocks to Keep Your Portfolio in Profit
by Rajani Lohia
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like B, PLUS, PAM, GIII and UFPI hold promise.
Why Fast-paced Mover ePlus (PLUS) Is a Great Choice for Value Investors
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, ePlus (PLUS) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
What Makes ePlus (PLUS) a New Strong Buy Stock
by Zacks Equity Research
ePlus (PLUS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Industry Outlook Highlights MSCI (MSCI), Tyler Technologies, Guidewire Software and ePlus
by Zacks Equity Research
MSCI (MSCI), Tyler Technologies, Guidewire Software and ePlus have been highlighted in this Industry Outlook article.
4 Business-Software Services Stocks to Watch in a Thriving Industry
by Anirudha Bhagat
The Zacks Business-Software Services industry players like MSCI, TYL, GWRE and PLUS are poised to continue benefiting from the increasing demand for multi-cloud-enabled software solutions amid the accelerated digital transformation and a shift to cloud initiatives.
EPlus (PLUS) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
ePlus (PLUS) delivered earnings and revenue surprises of 28.30% and 2.18%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Q2 Holdings (QTWO) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Q2 Holdings (QTWO) delivered earnings and revenue surprises of 180% and 2.20%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Cognizant (CTSH) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cognizant (CTSH) delivered earnings and revenue surprises of 5.71% and 1.60%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Tyler Technologies (TYL) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Tyler Technologies (TYL) delivered earnings and revenue surprises of 2.92% and 0.38%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Cognizant (CTSH) & Microsoft Expand Healthcare Partnership
by Zacks Equity Research
Cognizant (CTSH) announces the expansion of its partnership with Microsoft in the healthcare market by integrating its TriZetto with Microsoft Cloud for Healthcare.
Zacks.com featured highlights CNA Financial, Medallion Financial, ArcelorMittal, KB Home and ePlus
by Zacks Equity Research
CNA Financial, Medallion Financial, ArcelorMittal, KB Home and ePlus have been highlighted in this Screen of The Week article.